https://www.selleckchem.com/pr....oducts/wnt-agonist-1
The antibody titer decreased when the disease was improved by anti-mycobacterial treatment (p less then 0.01) and increased as the disease progressed (p less then 0.05). Even after the antibody titer decreased, the neutralizing capacity against IFN-γ was maintained by individual sera. CONCLUSIONS Despite the improvement in the pathological condition via treatment, the patients' sera maintained neutralizing capacity against IFN-γ. Antibody titer fluctuated over the course of the disease and exhibited potential as a biomarker fo
כמו
תגובה
לַחֲלוֹק
